Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
August 27, 2019
August 27, 2019
GENEVA, Switzerland, Aug. 27 -- Alcon, a division of Novartis, issued the following news release:
* * *
- Panoptix Delivers An Exceptional Combination Of Near, Intermediate And Distance Vision And Substantially Reduces The Need For Glasses/1,2
- More Than Ninety-Nine Percent Of Panoptix Patients In The FDA Clinical Study Said They Would Choose The Same Lens Again/1
* * *
Alcon (SIX/NYSE:ALC), the global leader in eye care, today an . . .
* * *
- Panoptix Delivers An Exceptional Combination Of Near, Intermediate And Distance Vision And Substantially Reduces The Need For Glasses/1,2
- More Than Ninety-Nine Percent Of Panoptix Patients In The FDA Clinical Study Said They Would Choose The Same Lens Again/1
* * *
Alcon (SIX/NYSE:ALC), the global leader in eye care, today an . . .